A Comparative Analysis of 4% Chlorhexidine Versus Methylated Spirit as Prophylaxis of Omphalitis and Sepsis in Newborns
NCT ID: NCT06002295
Last Updated: 2023-08-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
300 participants
INTERVENTIONAL
2020-09-12
2021-11-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Aims and Objectives: To compare the effectiveness of 4% chlorhexidine and methylated spirit in newborns for prevention of omphalitis and neonatal sepsis.
Materials and Methods: This randomized control trial was carried out in neonatal unit of Shaikh Zayed Hospital Lahore. After meeting the inclusion criteria, 300 neonates were enrolled. In group A 4% chlorhexidine was applied for cord care and in group B methylated spirit was used. Neonates were followed till 10th day of life. Careful examination was done for cord separation and for any signs of omphalitis or sepsis. If the neonate had no signs and symptoms of omphalitis and sepsis on 10th day of follow up then it was treatment success.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy Study of Community-Based Treatment of Serious Bacterial Infections in Young Infants
NCT00189384
Neonatal Bacterial Colonization Study
NCT03896893
Topical Umbilical Cord Care for the Prevention of Colonization and Invasive Infections
NCT01886001
Umbilical Cord Care for the Prevention of Colonization
NCT01893060
Efficacy And Safety Of Short Course Antibiotic Therapy In Preterm Neonates With Early Onset Sepsis
NCT06197269
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Neonatal sepsis in one of the leading causes of death in neonates in developing countries. Infection of the umbilical cord often leads to infection in the blood. World Health Organization (WHO) recommends 4% chlorhexidine to prevent omphalitis and neonatal sepsis. In Pakistan the investigators use methylated spirit for prophylaxis of omphalitis as 4% chlorhexidine is not available and expensive to use. Some commercial gels containing 2% chlorhexidine is available, but these are not as effective as methylated spirit.
Chlorhexidine gel is an antiseptic agent with broad-spectrum bactericidal and bacteriostatic properties effective against gram-negative bacteria and fungi with rapid pathogen killing rates. Methylated spirit on the other hand is both bactericidal, mycobactericidal, fungicidal, and viricidal agent.
In Pakistan Staphylococcal aureus is common pathogen in umbilical discharge. Some low cost prevention therapy should be used. Methylated spirit is commonly used for cord care. A study was conducted to explore about cord care practices in African setting which showed that 73.2% respondents consider methylated spirit as most important agent for cord care.
Chlorhexidine is available in different concentrations for antiseptic purpose. Efficacy of all concentrations is comparable but 4% chlorhexidine concentration is more effective in inhibiting organism's flora as compared to 2% chlorhexidine. Since then, multiple studies were done to compare between methylated spirit and 4% chlorhexidine. Methylated spirit is equally safe where 4% chlorhexidine is unavailable.
In Pakistan 57% deaths occur in neonatal period. Pakistan has highest neonatal mortality rate of 42 per 1000 live births. In developing countries neonatal sepsis is aggravated by home deliveries, antibiotic resistance and less medical staff. The most important way to decrease mortality and morbidity due to infections is prevention at an early stage. According to a study conducted in Karachi, omphalitis is 217.4/1000 live births from which moderate-severe omphalitis is 170/1000 live births and associated with sepsis is 20.4/1000 live births. Various antiseptics used in neonatal intensive care units include chlorhexidine, alcohol, iodine, hexachlorophene \& octenidine. Each agent having its own advantages and adverse effects. However best antiseptic is yet to be determined.
World Health Organization (WHO) recommends application for 4 percent chlorhexidine in high neonatal mortality area and methylated spirit for cord care while methylated spirit is commonly used agent for cord care. One study conducted shows that applying chlorhexidine on cord in neonatal intensive care unit decreases mortality rate and decreases time of separation of cord.
Methylated spirit and chlorhexidine both have comparable efficacy and can be used in areas of non-availability of chlorhexidine and whenever chlorhexidine is not safe to use as in very preterm neonates. In Pakistan there is no population based study published on this issue this study aimed to compare the effectiveness of methylated spirit and 4% chlorohexidine from prevention of omphalitis and neonatal sepsis. This study will help to establish the use of methylated spirit in prevention of omphalitis and neonatal sepsis at low price and easy availability.
Methodology:
It was a randomized controlled trial done at the Neonatology unit, Department of Pediatrics, Shaikh Zayed Hospital, Lahore. For a period of 12 months from September 2020 to September 2021 with the hypothesis that methylated spirit is equally effective as 4% chlorhexidine in preventing omphalitis and sepsis in neonate. 300 newborns were included by probability consecutive sampling in study with 150 newborns in each group with confidence interval of 95% and margin of error 5%. Sample size was calculated using Raosoft sample size calculator.
After approval from the hospital ethical committee, neonates fulfilling inclusion and exclusion criteria were selected. Written informed consent was obtained from the parents. Full instructions to avoid confounding variables like maintaining temperature and hygiene of newborn, frequent diaper change, avoidance of herbal tonics and cow milk were given to mothers.
In group "A" mothers were advised the topical application of 4% chlorhexidine generously over cord along with base of cord stump and surrounding skin thrice a day. In group "B" clean cotton swab dipped in methylated spirit was used to clean cord along with cord clamps and base thrice a day.
Neonates were followed till 10th day of life and careful examination was done for cord separation and any signs of omphalitis or sepsis. Primary outcome measure was omphalitis which was characterized by local inflamed cord. Secondary outcome measure was sepsis which was characterized by signs and symptoms such as fever, reluctance to feed, respiratory difficulty, irritability. Treatment success was labelled if there was no evidence of omphalitis or sepsis. If omphalitis or evidence of sepsis was present, the patient was treated as per hospital protocol. Data was collected according to proforma.
Statistical Analysis:
Data was entered in SPSS v.23.0 and was analyzed through it. The numeric variables like gestational age at birth and birth weight were presented as mean ± standard deviation, while the categorical variables like gender of the neonate, omphalitis and sepsis were presented as frequency (%). Both groups were compared for omphalitis and sepsis by using the chi-square (ﬡ²) test. P-value ≤ 0.05 was kept as significant. Data was stratified for gender of the neonate, gestational age at birth and birth weight to deal with the effect modifiers. Post-stratification, Chi-Square test was applied to compare both groups for omphalitis and sepsis in each strata. P-value ≤ 0.05 was kept as significant.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Umbilical Cord Care with Chlorhexidine (Group A)
Chlorhexidine Topical Cream
After approval from the hospital ethical committee, neonates fulfilling inclusion and exclusion criteria were selected. Written informed consent was obtained from the parents. Full instructions to avoid confounding variables like maintaining temperature and hygiene of newborn, frequent diaper change, avoidance of herbal tonics and cow milk; are given to mothers.
In group "A" 4% chlorhexidine was applied generously over cord along with base of cord stump and surrounding skin thrice a day. In group "B" clean cotton swab dipped in methylated spirit was used to clean cord along with cord clamps and base thrice a day.
Umbilical Cord Care with Methylated Spirit (Group B)
Methylated Spirit
After approval from the hospital ethical committee, neonates fulfilling inclusion and exclusion criteria were selected. Written informed consent was obtained from the parents. Full instructions to avoid confounding variables like maintaining temperature and hygiene of newborn, frequent diaper change, avoidance of herbal tonics and cow milk; are given to mothers.
In group "A" 4% chlorhexidine was applied generously over cord along with base of cord stump and surrounding skin thrice a day. In group "B" clean cotton swab dipped in methylated spirit was used to clean cord along with cord clamps and base thrice a day.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Chlorhexidine Topical Cream
After approval from the hospital ethical committee, neonates fulfilling inclusion and exclusion criteria were selected. Written informed consent was obtained from the parents. Full instructions to avoid confounding variables like maintaining temperature and hygiene of newborn, frequent diaper change, avoidance of herbal tonics and cow milk; are given to mothers.
In group "A" 4% chlorhexidine was applied generously over cord along with base of cord stump and surrounding skin thrice a day. In group "B" clean cotton swab dipped in methylated spirit was used to clean cord along with cord clamps and base thrice a day.
Methylated Spirit
After approval from the hospital ethical committee, neonates fulfilling inclusion and exclusion criteria were selected. Written informed consent was obtained from the parents. Full instructions to avoid confounding variables like maintaining temperature and hygiene of newborn, frequent diaper change, avoidance of herbal tonics and cow milk; are given to mothers.
In group "A" 4% chlorhexidine was applied generously over cord along with base of cord stump and surrounding skin thrice a day. In group "B" clean cotton swab dipped in methylated spirit was used to clean cord along with cord clamps and base thrice a day.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Antiseptic agent started from 1st day of life \& up to 10 days continued without missing dose
Exclusion Criteria
* Laboratory or clinical evidence of sepsis.
* Preterm newborns
* Newborns having very low birth weight \<1.5 kg
* Any evidence of asphyxia during birth.
1 Day
10 Days
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sheikh Zayed Federal Postgraduate Medical Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmad Zunair Wasim
Resident Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sheikh Zayed Federal Postgraduate Medical Institute
Lahore, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SZMC/IRB/Internal/MD/130/19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.